First-line therapy in T2D: Has Metformin been “dethroned

Authors

Joshua J Neumiller, ProvidenceFollow
Radica Alicic, ProvidenceFollow

Document Type

News Article

Publication Date

8-1-2023

Keywords

washington; prmc; spokane

Area of Special Interest

Kidney & Diabetes

Specialty/Research Institute

Endocrinology

Specialty/Research Institute

Nephrology

Comments

Medscape